-
241
Clinical Usefulness of Atrioventricular Coupling in Cardiovascular Disease
Published 2025-03-01Subjects: “…|echocardiography|atrioventricular coupling|left atrioventricular coupling index|heart failure|atrial fibrillation…”
Get full text
Article -
242
Impact of Silent Cerebral Embolism during and after Left Atrial Appendage Occlusion on Long‐Term Cognitive Function
Published 2025-02-01Subjects: Get full text
Article -
243
Surgical treatment of obesity and excess risk of developing heart failure in a controlled cohort study
Published 2022-06-01Subjects: Get full text
Article -
244
From memory impairment to two occluders in the heart – a multidisciplinary case report
Published 2021-12-01Subjects: Get full text
Article -
245
Direct Oral Anticoagulants Versus Vitamin K Antagonists After Mitral Valve Transcatheter Edge‐to‐Edge Repair in Patients With Atrial Fibrillation: A Single‐Center Observational Study
Published 2025-02-01“…Background Mitral valve transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a viable therapy option in patients with severe mitral regurgitation and high surgical risk. Although atrial fibrillation is common among patients undergoing M‐TEER, the optimal anticoagulatory treatment after the intervention is unknown. …”
Get full text
Article -
246
Study on the Curative Effect and Safety of Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation via Zero-Fluoroscopy Transseptal Puncture under the Dual Guidance of Electroanatomical Mapping and Intracardiac Echocardiography
Published 2021-01-01“…Similarly, there was also no significant difference in the recurrence rate of atrial fibrillation between the EAM-ICE and F groups (25.5% vs. 18.2%, p=0.356). …”
Get full text
Article -
247
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registry
Published 2025-01-01“…Aims This study aimed to determine the robustness, reproducibility and representativeness of the landmark Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (AF) (ARISTOTLE) and Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in AF (ROCKET AF) randomised trials through replication in an observational AF patient registry.Methods and results Patients from the Global Anticoagulant Registry in the FIELD (GARFIELD)-AF registry treated with apixaban, rivaroxaban or vitamin K antagonist (VKA) were assessed for eligibility for the ARISTOTLE and ROCKET AF trials. …”
Get full text
Article -
248
Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care
Published 2022-06-01“…Objectives To investigate effects of appropriately and inappropriately dosed apixaban/rivaroxaban versus warfarin on effectiveness and safety outcomes in patients with non-valvular atrial fibrillation (NVAF).Design Cohort study with nested case–control analyses using primary care electronic health records (IQVIA Medical Research Data UK database).Setting UK primary care.Participants Patients aged ≥18 years with NVAF newly prescribed apixaban (N=14 701), rivaroxaban (N=14 288) or warfarin (N=16 175) between 1 January 2012 and 30 June 2018, and followed up to 31 December 2018.Primary and secondary outcome measures Incident cases of ischaemic stroke/systemic embolism (IS/SE) and intracranial bleeding (ICB). …”
Get full text
Article -
249
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
Published 2012-12-01“…Objective Three oral anticoagulants have reported study results for stroke prevention in patients with atrial fibrillation (AF) (dabigatran etexilate, rivaroxaban and apixaban); all demonstrated superiority or non-inferiority compared with warfarin (RE-LY, ARISTOTLE and ROCKET-AF). …”
Get full text
Article -
250
Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
Published 2025-03-01Subjects: “…Atrial fibrillation…”
Get full text
Article -
251
Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis
Published 2025-01-01Subjects: “…Atrial fibrillation…”
Get full text
Article -
252
Hypermethylation of Hif3a and Ifltd1 is associated with atrial remodeling in pressure-overload murine model
Published 2025-01-01Subjects: “…Atrial fibrillation…”
Get full text
Article -
253
-
254
Recognition of biosignals with nonlinear properties by approximate entropy parameters
Published 2023-10-01Subjects: Get full text
Article -
255
Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS).
Published 2025-01-01“…<h4>Background</h4>Risk factors and comorbidities can complicate management of non-valvular atrial fibrillation. We describe and compare real-world safety and effectiveness of direct oral anticoagulants (DOACs; apixaban, rivaroxaban, dabigatran) and vitamin K antagonists (VKAs) in subgroups of patients with non-valvular atrial fibrillation at high risk for gastrointestinal (GI) bleeding, utilizing data from a national quasi-exhaustive French database.…”
Get full text
Article -
256
Heart rhythm disorders and features of their management at COVID-19 pandemic
Published 2021-10-01Subjects: Get full text
Article -
257
Risk factors for long-term severe tricuspid regurgitation following mitral valve replacement: a retrospective study
Published 2025-01-01Subjects: “…Atrial fibrillation…”
Get full text
Article -
258
Anderson–Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies
Published 2025-01-01Subjects: Get full text
Article -
259
Atrial flutter/fibrillation in adult congenital heart disease: Insights from a large Asian cohort
Published 2025-02-01Subjects: Get full text
Article -
260